Decision Resources acquires Manhattan Research

Share this article:

Decision Resources announced the acquisition of Manhattan Research on June 17.  The move will expand Decision Resources' global physician and consumer digital market research portfolio, according to a statement.  Terms of the deal were not disclosed to the public.

“Part of Decision Resources' big goal is to grow our business both organically, and to build a stable of premier market research firms that focus on specific areas of the healthcare industry,” said Elizabeth Marshall, director of marketing at Decision Resources.  Marshall cites Millennium Research Group and HealthLeaders as two examples of other research firms providing Decision Resources with a specialized focus: Millennium for medical devices and technology, and HealthLeaders for managed care.  “We're looking at the bigger picture and the healthcare industry as a whole – we're offering clients an integrated model,” says Marshall.  

Manhattan Research will remain headquartered in New York, NY.  Decision Resources is located in Waltham, MA.  Other companies owned by Decision Resources include Arlington Medical Resources, which was acquired last December, and Fingertip Formulary, acquired in March. 

Share this article:

Email Newsletters

More in News

Five things for pharma marketers to know: Friday, August 22

Five things for pharma marketers to know: Friday, ...

Two new indications give Eliquis more juice, a new rule is making hydrocodone harder to get and the ALS Ice Bucket Challenge highlights a controversial aspects of drug discovery and ...

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.